BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19503103)

  • 1. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
    Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
    Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.
    Garcia BL; Summers BJ; Ramyar KX; Tzekou A; Lin Z; Ricklin D; Lambris JD; Laity JH; Geisbrecht BV
    J Biol Chem; 2013 Jan; 288(4):2870-81. PubMed ID: 23233676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
    Garcia BL; Ramyar KX; Tzekou A; Ricklin D; McWhorter WJ; Lambris JD; Geisbrecht BV
    J Mol Biol; 2010 Sep; 402(1):17-29. PubMed ID: 20654625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric inhibition of complement function by a staphylococcal immune evasion protein.
    Chen H; Ricklin D; Hammel M; Garcia BL; McWhorter WJ; Sfyroera G; Wu YQ; Tzekou A; Li S; Geisbrecht BV; Woods VL; Lambris JD
    Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17621-6. PubMed ID: 20876141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
    Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
    J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
    Ponnuraj K; Xu Y; Macon K; Moore D; Volanakis JE; Narayana SV
    Mol Cell; 2004 Apr; 14(1):17-28. PubMed ID: 15068800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family.
    Garcia BL; Summers BJ; Lin Z; Ramyar KX; Ricklin D; Kamath DV; Fu ZQ; Lambris JD; Geisbrecht BV
    J Biol Chem; 2012 Jan; 287(1):628-640. PubMed ID: 22086928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of C3b in complex with factors B and D give insight into complement convertase formation.
    Forneris F; Ricklin D; Wu J; Tzekou A; Wallace RS; Lambris JD; Gros P
    Science; 2010 Dec; 330(6012):1816-20. PubMed ID: 21205667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.
    Summers BJ; Garcia BL; Woehl JL; Ramyar KX; Yao X; Geisbrecht BV
    Mol Immunol; 2015 Oct; 67(2 Pt B):193-205. PubMed ID: 26052070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
    Krishnan V; Ponnuraj K; Xu Y; Macon K; Volanakis JE; Narayana SV
    Structure; 2009 Apr; 17(4):611-9. PubMed ID: 19368894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/function of C5 convertases of complement.
    Rawal N; Pangburn MK
    Int Immunopharmacol; 2001 Mar; 1(3):415-22. PubMed ID: 11367526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a staphylococcal complement inhibitor with broad host specificity in equid
    de Jong NWM; Vrieling M; Garcia BL; Koop G; Brettmann M; Aerts PC; Ruyken M; van Strijp JAG; Holmes M; Harrison EM; Geisbrecht BV; Rooijakkers SHM
    J Biol Chem; 2018 Mar; 293(12):4468-4477. PubMed ID: 29414776
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural biology of the alternative pathway convertase.
    Xu Y; Narayana SV; Volanakis JE
    Immunol Rev; 2001 Apr; 180():123-35. PubMed ID: 11414354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
    Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):882-7. PubMed ID: 19136636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
    Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
    J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.
    Woehl JL; Stapels DAC; Garcia BL; Ramyar KX; Keightley A; Ruyken M; Syriga M; Sfyroera G; Weber AB; Zolkiewski M; Ricklin D; Lambris JD; Rooijakkers SHM; Geisbrecht BV
    J Immunol; 2014 Dec; 193(12):6161-6171. PubMed ID: 25381436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of human complement component C3b in the presence of a staphylococcal complement-inhibitor protein (SCIN).
    Garcia BL; Tzekou A; Ramyar KX; McWhorter WJ; Ricklin D; Lambris JD; Geisbrecht BV
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May; 65(Pt 5):482-5. PubMed ID: 19407382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N; Pangburn M
    J Immunol; 2001 Feb; 166(4):2635-42. PubMed ID: 11160326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement.
    Katschke KJ; Stawicki S; Yin J; Steffek M; Xi H; Sturgeon L; Hass PE; Loyet KM; Deforge L; Wu Y; van Lookeren Campagne M; Wiesmann C
    J Biol Chem; 2009 Apr; 284(16):10473-9. PubMed ID: 19196712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.